NMC

NEA Management Company Portfolio holdings

AUM $1.33B
This Quarter Return
+2.46%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$2.36B
AUM Growth
+$2.36B
Cap. Flow
+$103M
Cap. Flow %
4.35%
Top 10 Hldgs %
55.13%
Holding
55
New
9
Increased
3
Reduced
6
Closed
1

Top Buys

1
NKTX icon
Nkarta
NKTX
$87.3M
2
ANNX icon
Annexon
ANNX
$75.5M
3
INZY
Inozyme Pharma
INZY
$64.3M
4
MTCR
Metacrine, Inc. Common Stock
MTCR
$31.3M
5
VRNA
Verona Pharma
VRNA
$24.3M

Top Sells

1
SPT icon
Sprout Social
SPT
$133M
2
CRSP icon
CRISPR Therapeutics
CRSP
$41.9M
3
MRSN icon
Mersana Therapeutics
MRSN
$37.2M
4
RIGL icon
Rigel Pharmaceuticals
RIGL
$5.94M
5
NET icon
Cloudflare
NET
$5.32M

Sector Composition

1 Healthcare 83.31%
2 Technology 10.27%
3 Consumer Discretionary 1.95%
4 Industrials 1.01%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SPT icon
1
Sprout Social
SPT
$929M
$215M 9.12% 5,596,080 -3,450,000 -38% -$133M
ALLK
2
DELISTED
Allakos
ALLK
$185M 7.82% 2,268,188 – –
ADAP
3
Adaptimmune Therapeutics
ADAP
$15.6M
$136M 5.77% 17,082,611 – –
CRSP icon
4
CRISPR Therapeutics
CRSP
$4.71B
$133M 5.63% 1,590,002 -500,676 -24% -$41.9M
OYST
5
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$125M 5.3% 5,925,287 – –
MRSN icon
6
Mersana Therapeutics
MRSN
$36.5M
$111M 4.7% 5,959,520 -2,000,000 -25% -$37.2M
RYTM icon
7
Rhythm Pharmaceuticals
RYTM
$6.85B
$106M 4.51% 4,912,306 – –
BDTX icon
8
Black Diamond Therapeutics
BDTX
$157M
$104M 4.42% 3,449,845 – –
AKUS
9
DELISTED
Akouos, Inc. Common Stock
AKUS
$98.3M 4.16% 4,298,488 – –
NKTX icon
10
Nkarta
NKTX
$151M
$87.3M 3.7% +2,904,974 New +$87.3M
ELVN icon
11
Enliven Therapeutics
ELVN
$1.2B
$81.7M 3.46% 4,017,170 – –
TRIL
12
DELISTED
Trillium Therapeutics Inc.
TRIL
$81.5M 3.45% 5,736,363 – –
MIRM icon
13
Mirum Pharmaceuticals
MIRM
$3.71B
$80.7M 3.42% 4,187,801 – –
AUPH icon
14
Aurinia Pharmaceuticals
AUPH
$1.58B
$76.2M 3.23% 5,172,683 – –
ANNX icon
15
Annexon
ANNX
$226M
$75.5M 3.2% +2,497,661 New +$75.5M
ARDX icon
16
Ardelyx
ARDX
$1.53B
$71.6M 3.03% 13,633,582 – –
INZY
17
DELISTED
Inozyme Pharma
INZY
$64.3M 2.72% +2,444,379 New +$64.3M
CSPR
18
DELISTED
Casper Sleep Inc.
CSPR
$44.8M 1.9% 6,226,130 +90 +0% +$647
GRTX
19
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$39.4M 1.67% 4,362,986 – –
VRNA
20
Verona Pharma
VRNA
$9.16B
$31.9M 1.35% 5,108,563 +3,888,889 +319% +$24.3M
MTCR
21
DELISTED
Metacrine, Inc. Common Stock
MTCR
$31.3M 1.32% +3,062,977 New +$31.3M
CBIO
22
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
$27.9M 1.18% 9,089,041 – –
MEIP icon
23
MEI Pharma
MEIP
$160M
$26.6M 1.13% 8,533,072 – –
BE icon
24
Bloom Energy
BE
$12.4B
$24M 1.01% 1,333,333 – –
TRVI icon
25
Trevi Therapeutics
TRVI
$883M
$23.9M 1.01% 5,940,796 – –
1
2 3